Go RW!!!!!! You are so right about the patients. I love how the article states they are hoping to find a "balanced way" of letting investors know about the PML risks. Ha ha ha. That is shorthand for "leaking as little information as possible."
In the meantime, there have been 3 more PML cases added to the German blog for November.

All it states is that the info came from an "internal Biogen paper." If this is true that would now make 27 post-marketing cases.
http://chefarztfrau.de/?page_id=716
RW, do you know anything about this?